BioCryst Pharmaceuticals shares owned by Hillsdale Investment Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Hillsdale Investment Management
from 13F filings
Historical chart of Hillsdale Investment Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in BioCryst Pharmaceuticals by Hillsdale Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.3M | 562k | 7.59 |
| 2025-06-30 | $4.8M | 536k | 8.96 |
| 2025-03-31 | $3.9M | 522k | 7.50 |
| 2024-12-31 | $4.1M | 542k | 7.52 |
| 2024-09-30 | $6.3k | 830 | 7.60 |
| 2020-06-30 | $820k | 172k | 4.77 |
More positions owned by Hillsdale Investment Management
View all positions for Hillsdale Investment Management